mgc-blm
Brendan McKernan
CEO

Brendan has spent his career utilizing world class operating principles in the life science and clinical diagnostic industries. The Medicinal Genomics (MGC) team has a finite attention to detail to ensure that MGC can and will produce the finest quality products in the world. This approach has been part of MGCs culture and a strong passion of Brendan’s his entire career. Brendan has had the opportunity to work with incredibly bright scientists, entrepreneurs and business professionals while building Agencourt Bioscience, Agencourt Personal Genomics, Courtagen Life Sciences and Medicinal Genomics.

Brendan holds a BS in Management Science from Muhlenberg College and an MBA from Rensselaer’s Lally School of Management and Technology. While at Rensselaer, Brendan received the Delmar W. Karger Award in Management for outstanding academic and leadership achievements. In 2006 Brendan was named the William F. Glaser ’53 Rensselaer Entrepreneur of the Year. Brendan is also a board member of the Avon Old Farms School where he serves as Co-Vice Chairman and Treasurer. In addition, Brendan is a member of Boston Harbor Angels and an advisor to Rensselaer’s Lally School of Management and Technology. When not not pushing for lean manufacturing concepts, Brendan enjoys boating and martial arts.

kevin_new
Kevin McKernan
CSO & Founder

Kevin has spent his career researching and developing various DNA sequencing technologies in both the research and clinical industries. Additionally  Kevin has had a parallel interest in driving the tools used for personalized medicine into the world of cannabis medicine.  Kevin believes the intersection of personalized medicine, genomics, blockchains and cannabis is one of the most exciting growth opportunities in our lifetime.  Kevin is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment (Kannapedia.net) for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics. Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and held the position of Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLiD sequencing technology. Integral to the SOLiD R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next generation sequencing and saw particular excitement and traction in human tumor sequencing. Kevin initiated an R&D project to investigate chemFET semiconductor based DNA sequencing and spearheaded a process to acquire the DNA sequencing company Ion Torrent for $350M. These collaborations resulted in hundreds of publications and 7 Journal covers from Science Translational Medicine to Nature.

Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost in a few years. Kevin oversaw the growth and research of APG until it was sold it to Applied BioSystems.  In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until 2005 where it was acquired by Beckman Coulter. From 1996 to 2000 Kevin managed the Research and Development for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters.  When not decoding DNA and unraveling the mysteries of cannabis medicine, Kevin enjoy boating, skiing, and gardening.

holland_new
Elizabeth Holland
Vice President, Human Resources

Elizabeth has long been an advocate of cannabis legalization, cannabis genetics and safety and is proud to be  part of a team of people who are bringing state-of-the-art technology to cannabis plant genetics.

Elizabeth has over 20 years of experience in the role of Human Resource Business Partner. Elizabeth has been the human resource lead in several mergers, acquisitions and divestures. She has worked in the biotechnology industry since 1996 with with drug discovery, genomics, and medical device companies. Elizabeth graduated from Northeastern University and holds her Senior Professional Human Resources Certification (SPHR). She is a member of Northeast Human Resources Association (NEHRA) and the Society of Human Resource Management (SHRM). Elizabeth was a Chair at the Massachusetts Biotechnology Company for ten years and is one of the founders of HRBiotech Connect, a group formed in 2006 to provide a forum for senior level human resource business partners to debate and discuss current issues.  Elizabeth currently resides in Boulder, Colorado and travels to the east coast on a regular basis.

tim_new
Tim Olcott
Vice President, Operations

Tim has spent the last 15 years  working in the genomics space alongside many of the MGC team members.  Before joining MGC, Tim was Vice President, Customer Support & Logistics for Courtagen Life Sciences, Inc.  where he focused on building a world class sequencing laboratory operation and managed all aspects of order management and customer support. 

Tim worked for Agencourt Bioscience from its 2001 inception through its acquisition by Beckman Coulter in 2006, leaving in 2007 to pursue an MBA. Throughout Agencourt’s rapid growth, Tim worked in manufacturing services. His responsibilities included purchasing, inventory planning and control, quality management, facilities management, and new product development. Most notably Tim led a task force that implemented lean manufacturing practices in the laboratory, maintaining a low cost structure to drive margins and other key indicators. Tim applied these same skills and had similar responsibilities at Courtagen. Tim also served on the New Product Development committee at Agencourt as well as at Courtagen and managed the release of several successful product launches at both companies.

Tim earned his undergraduate degree in Business/Finance at the University of Colorado at Boulder. He left Agencourt in 2007, a year after the merger with Beckman Coulter, to pursue an MBA at Babson College. While studying at the F.W. Olin Graduate School of Business at Babson College he worked as an intern for the Boston Harbor Angel group coordinating deal screening and due diligence activities. Tim graduated from Babson in June of 2009.  When out of the office Tim can usually be found enjoying the outdoors with his wife and two kids, most often golfing or skiing.

_MG_3762 – Version 3
Doug Kennedy
Director, CannMed Events

Doug Kennedy joined Medicinal Genomics at the onset of co-founding CannMed Events in 2016.  Previously Doug worked at  Courtagen Life Sciences team as Director, Non-Profit and Volunteer Outreach.  Doug has more than twenty years of experience in providing humanitarian aid in impoverished regions around the world. His work in Honolulu included developing the New Hope Relief program and leading more than 200 medical, first response, and community development outreach programs in Southeast Asia and the South Pacific. Following the Indian Ocean tsunami in 2004, his relief efforts included working as a producer on the film “The Third Wave”, which was screened in the first ever Presidential Jury Screening in the 2008 Cannes Film Festival and resulted in the development of CTEC – a community based tsunami warning center in Peraliya, Sri Lanka.

In 2009, he joined the staff of the Happy Hearts Fund as the Director of Volunteers where he developed multiple platforms for individuals and groups to participate in providing second wave response efforts following natural disasters including, nationwide fundraising teams to benefit the construction of schools, a New York City based intern program that played an active role with the Clinton Global Initiative, an online education program to equip students around the world in response to natural disasters, and traveled extensively to impacted regions for the purpose of nurturing the relationship between HHF and donors.

He currently resides in New York and Honolulu and continues as a consultant for non-profit organizations in volunteer development. At the core of all he does is his goal to see people realize the joy found when they apply their skills and passions to meet the needs of others.

ebling1_new
Heather Ebling
Sr. Applications Scientist

Heather joined the Medicinal Genomics team in 2015 to provide technical support to both R&D and customers.  Previously Heather was an Application Scientist supporting reagents and automation for Courtagen Life Sciences, Perkin Elmer and Beckman Coulter.  Heather began her career at the bench making DNA libraries which contributed to the sequencing of chromosome 10 of the Human Genome Project at Genome Therapeutics.  GTC was acquired by Agencourt Bioscience in 2003.  Heather continued to work with the Agencourt team through the Beckman Coulter acquisition as she transitioned into Project Management and technical customer support and training.   Heather is a graduate of Florida Atlantic University where she earned her Bachelor’s degree in Biology.

yvonne_new
Yvonne Helbert
Sr. Scientist

Yvonne and has been a key member of the R&D team that has produced high quality products for Medicinal Genomics.  Previously to MGC, Yvonne worked at Courtagen Life Sciences and was instrumental in the development of several clinically actionable assays.  Prior to joining Courtagen, she was a Senior Development Scientist at Beckman Coulter Genomics (formerly Agencourt Bioscience). While there she was part of a team that developed and validated The Agencourt Genfind™ v2 gDNA Isolation Kit and Viral Nucleic Extraction Kit. She was also a key member of the Molecular Diagnostics Research and Development team.

Yvonne was also a Senior Laboratory Technician at The Center of Human Genetics at Boston University School of Medicine. There she performed over a half a million genotype experiments on samples from more than three thousand patients. She also built the laboratory’s mass spectrometry program for single nucleotide polymorphism detection, and she was responsible for all such experiments conducted in the lab.

Yvonne received her Bachelor’s degree in Biology from Syracuse University and Master’s degree in Biochemistry from Boston University School of Medicine.

ben
Ben Amirault
Marketing Manager

I am a well-rounded marketing professional with experience in digital marketing, lead generation, social media, design, and content creation. I started my career as the editor of a healthcare coding and billing newsletter. While it was not nearly as exciting as working in the cannabis space, I learned how to explain complex topics in a simple and effective manner. That skill comes in handy at MGC. The science team is doing some amazing, innovative things in the lab, and I welcome the challenge of trying to simplify it for the layman. In addition to doing all things marketing for MGC, I also maintain Kannapedia.net and help organize and execute our annual CannMed Conference. In my spare time, I enjoy running, playing soccer, supporting the New England sports teams, and spending time with my family.

kate
Kate Landry
Controller

Kate has spent over twelve years working in various accounting and tax roles in both public and private corporations.  Most recently Kate was employed at Courtagen Life Sciences in the position of Senior Accountant before joining MGC as Controller.  Kate received a BS in Marketing and MSA from Bentley University.  In her spare time, Kate enjoys traveling volunteering and knitting.

zac
Zac Eaton
Senior Sales Representative

I have been in the clinical diagnostic space for most of my professional career. A long-time cannabis grower, enthusiast, and legalization supporter, now I get to utilize my knowledge of genetics and passion for cannabis to help ensure safe, quality products hit the medical and recreational markets around the world.

Born and raised in Maine, I now live in Rhode Island with my wife and our 2 kids. When I’m not helping our clients improve their operations, you can find me at the beach, my indoor garden, on the ski slopes, or just traveling around New England on a family adventure.

kyle
Kyle Boyar
Sales Representative

Kyle Boyar is a cannabis scientist with a background in neurobiology and analytical chemistry who has been working in the industry for five years. Kyle received his Bachelor’s degree in Neuroscience from the University of California Santa Cruz and was previously employed as a Laboratory Manager for SC Laboratories. In addition to his work with Medicinal Genomics he also serves as the Social Media Coordinator for the American Chemical Society’s Cannabis Chemistry Subdivision.

blair
Blair Beach
Customer Support Specialist

I joined the Medicinal Genomics team after working for over 2 years with Courtagen Life Sciences. During my time at CLS I was able to get a glimpse of what MGC was building, and the great possibilities that the field has to offer. To be involved in an industry that is bringing hope and change to people, and their families, with life-altering illnesses is a tremendous opportunity. Public opinion is becoming more and more favorable towards medicinal cannabis, and it is the progress in science and technology that is fueling that. I am excited to be in a position to assist our team, as well as our customers, in navigating this quickly growing industry.

denise
Denise Marston
Executive Assistant/Office Manager

I am proud to be working with all of the talented folks on the Medicinal Genomics Team in this exciting industry to ensure safe, quality cannabis.  With extensive experience in  office management,  I’m ready to help build this Company to infinity and beyond.

A true New Englander, I love the mountains and the beach, watching Boston sports teams, and spending time with my husband and two teenagers.